1. Home
  2. ONCY vs NUKK Comparison

ONCY vs NUKK Comparison

Compare ONCY & NUKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$1.24

Market Cap

94.0M

Sector

Health Care

ML Signal

HOLD

Logo Nukkleus Inc.

NUKK

Nukkleus Inc.

HOLD

Current Price

$2.82

Market Cap

67.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONCY
NUKK
Founded
1998
2013
Country
Canada
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
94.0M
67.9M
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
ONCY
NUKK
Price
$1.24
$2.82
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
1.1M
1.5M
Earning Date
03-06-2026
02-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$2.77
52 Week High
$1.51
$31.30

Technical Indicators

Market Signals
Indicator
ONCY
NUKK
Relative Strength Index (RSI) 64.88 30.68
Support Level $0.98 $3.03
Resistance Level $1.30 $3.87
Average True Range (ATR) 0.08 0.40
MACD 0.03 -0.03
Stochastic Oscillator 79.97 0.07

Price Performance

Historical Comparison
ONCY
NUKK

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

About NUKK Nukkleus Inc.

Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically operates in USA, UK and Malta, with majority of revenue from United Kingdom (UK).

Share on Social Networks: